PDA

View Full Version : Oral COTI-2 Is Effective Against Aggressive Triple Negative Human Breast Cancer


News
03-31-2010, 03:14 AM
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced positive test results today from a series of animal experiments carried out at a prominent Canadian cancer research facility with COTI-2 as a single agent against an aggressive strain of triple negative human breast cancer (TNBC); MDA-MB-231-luc...

More... (http://mnt.to/f/3zDQ)